In a recent conversation with Patient Care,® obesity and weight management expert Caroline Apovian, MD, emphasized for primary care clinicians that GLP-1 receptor agonists when used for chronic weight management should be paired with patient counseling for an optimal outcome.
Caroline M Apovian, MD, is a professor of medicine a Harvard Medical School and codirector of the Center for Weight Management and Wellness in the division of endocrinology, diabetes, and hypertension at Brigham and Women's Hospital in Boston, MA. Apovian is one of the founding creators of the American Board of Obesity Medicine, the body that provides certification and recognition for physicians who have specialized knowledge and training in the practice of obesity medicine.